Migration inducting gene 7

Migration inducting gene 7 (Mig-7 or Mig7) is a is_associated_with::gene. The protein is is_associated_with::cysteine-rich, and localized to the is_associated_with::cell membrane and is_associated_with::cytoplasm. It is the first-in-class of novel proteins translated from what are thought to be long is_associated_with::Non-coding RNAs.

Induction of Mig-7 expression occurs downstream of is_associated_with::Epidermal growth factor/is_associated_with::Epidermal growth factor receptor, is_associated_with::Cox-2/PGE-2 or is_associated_with::Hepatocyte growth factor/is_associated_with::c-Met activation and signalling. Data has shown that Mig-7 expression is specific to human embryonic/fetal is_associated_with::cytotrophoblast cells and epithelial type cancer cells, while not expressed in normal cells. Data demonstrate that targeting of Mig-7 simultaneously inhibits more than one cancer-progressing pathway while likely sparing normal cells.

Expression
Mig-7 expression is found on, as well as in, epithelial is_associated_with::tumor cells at the primary site, secondary (metastatic) sites, and blood from cancer patients. It is not produced by cells of normal human tissues or by cells from patients with inflammation but is expressed by epithelial precancerous and is_associated_with::malignant cells. It is also expressed in fetal/embryonic cytotrophoblast cells of early is_associated_with::placenta.

Mig-7 expression increases in malignant cancers. There is a high sensitivity and specificity of Mig-7 detection in breast (98% n=48 of 49), uterine (100% n=49), gastric (94.5% n=104 of 110) and lung (100% n=89) cancers.

Function and role in cancer
Mig-7 is thought to promote is_associated_with::carcinoma cell invasion, metastasis and tumor growth through is_associated_with::vasculogenic mimicry, a process where tumor cells form channels for fluids to flow through. It also promotes is_associated_with::epithelial–mesenchymal transition (EMT), a key developmental program that is often activated during, and required for, cancer invasion/metastasis. Mig-7 induces EMT through is_associated_with::hyperactivation of is_associated_with::Akt and extracellular regulated Kinase ERK1/2 by inhibiting the tumor suppressor protein phosphate 2A.

Mig-7 has been associated with signaling pathways downstream of epithelial type cancer-promoting kinases. It is expressed prior to TWIST, the previously named “master regulator” of EMT. It has also been shown to promote tumor is_associated_with::neovascularization.

Cancer cell metabolism (also known as oxidative glycolysis or the is_associated_with::Warburg effect) is a proposed cancer target and is likely regulated by Mig-7 through its hyperactivation of Akt.

Targeting of Mig-7
Targeting of Mig-7 with Mig-7-specific peptides significantly stimulates breast cancer patients’ immune cells’ killing of breast carcinoma cells is_associated_with::ex vivo. Targeting with is_associated_with::antibody generated to the peptide representing the first nine amino acids of Mig-7 detects cells expressing this protein and significantly inhibits carcinoma cell invasion in vitro. Targeting with short is_associated_with::hairpin RNA, specific to decrease Mig-7 protein levels, inhibits carcinoma cell invasion and metastasis as well as returns ERK1/2, Akt, GSK, and S6 kinase to normal is_associated_with::phosphorylation states through reactivation of PP2A.